All staff who can work at home should continue to do so. Only with an explicit request from a supervisor should a staff member return to campus. For more information, review COVID-19 Workplace Guidance.
Yale IRBs– Yale University Institutional Review Boards
The Yale HRPP provides administrative and regulatory support to 6 Institutional Review Boards (IRBs) for biomedical research known as Human Investigation Committees (IRB I, IRB 2, IRB 3, IRB 4, IRB B-1 Oncology, IRB B-3 Oncology,) and one IRB for social, behavioral and educational research known as IRB A, Human Subjects Committee (HSC). In addition, IRB 0 is an Ad Hoc panel that reviews all types of research and can meet on demand, IRB C reviews Compliance and Complex Issues, and IRB D reviews Repository protocols.
Biomedical studies are assigned to the next available weekly IRB meeting regardless of the department the study comes from. Oncology studies will continue to be scheduled to the oncology-focused IRB meetings on the 1st and 3rd weeks of the month, but they can also be sent to a week 2 or 4 biomedical IRB panel or the Ad Hoc panel. The purpose of the change is to improve the Yale internal IRB’s timelines for review and approval.
In addition to the above Yale IRB panels, research can also be sent to an external IRB for review. For more information, see external IRBs page and the following procedure: 920 PR. 4 Use of external IRBs for Review and Oversight of Research Involving Human Subjects.